Tris Pharma

Develops and sells medicines for ADHD and neurological disorders.

Founded 2000 · 500 employees · United States · Private

Funding:

Grant · $16.6M · 2023

Subsidiaries:

Park Therapeutics, NextWave Pharmaceuticals